90% Success Rate for New Cancer Treatment.
CAR-T cell therapy, a novel cancer therapy created by an Israeli institution, has proven to be remarkably effective in treating multiple myeloma, an untreatable form of cancer.
90% of the 74 patients who got the experimental medication in a study at Hadassah University Medical Centre experienced remission.
Cancer treatment could be revolutionised by CAR-T therapy, which uses the patient’s own immune system to target and kill cancer cells.
Following clinical trials and FDA approval, the therapy should be accessible in the US within a year.